Takeda's Partner Merges With Crestovo to Form Finch Therapeutics Group Post author:Sam Post published:October 22, 2017 Post category:BioPharma Two privately-held biotechs have merged to tackle recurrent C. difficile infections. Source: BioSpace You Might Also Like Verastem Reports Year-End 2016 Financial Results March 23, 2017 What You Need to Know About BlueRock Therapeutics January 2, 2018 Milestone Scientific CEO Steps Down Months After Taking Job, Interim Leader Named October 5, 2017
